Natalia Szczepańska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Natalia Szczepańska has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandra Ciarka
Department of Pathomorphology, Faculty of Medicine, Medical University of Gdańsk, 80-210 Gdańsk, Poland
2 shared publications - Julia Niedzielska
Faculty of Medicine, Medical University of Gdańsk, Poland
2 shared publications - Rafał Pęksa
Department of Pathomorphology, Medical University of Gdańsk, Gdańsk, Poland
2 shared publications - Tomasz Marjanski
Department of Thoracic Surgery, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland
2 shared publications - Aleksandra Czapla-Iskrzycka
Department of Endocrinology and Internal Diseases, Faculty of Medicine, Medical University of Gdansk, Poland
1 shared publication - Ewa Milnerowicz-Nabzdyk
Clinical Department of Gynecological Oncology, Centre of Oncology, Faculty of Medicine, University of Opole, Poland
1 shared publication
Latest Publications
- Open Access
- 15 October 2026
- Published by Wroclaw Medical University in Advances in Clinical and Experimental Medicine
- Vol. 35 (10) , 1747-1756
A multidisciplinary diagnostic approach to thoracic endometriosis syndrome: Insights from CT imaging, surgery, and pathology
Thoracic endometriosis syndrome (TES) is the most common extrapelvic manifestation of endometriosis, yet its classification, diagnosis, and treatment remain debated. Thoracic endometriosis syndrome has recently been proposed to be categorized into 3 types: pleural, bronchopulmonary, and diaphragmatic. Our study aims to propose a 3-step approach - computed tomography (CT) imaging, careful intraoperative assessment, and targeted pathology - to enhance the diagnostic process and optimize the management of TES-related pneumothorax. We retrospectively analyzed 3 cases of recurrent right-sided catamenial pneumothorax in female patients with a history of pelvic endometriosis, managed surgically at the Department of Thoracic Surgery, Medical University of Gdansk, between 2021 and 2024. All included patients underwent video-assisted thoracoscopic surgery (VATS), with comprehensive preoperative CT imaging, intraoperative lesion mapping, and postoperative histopathological examination, improving diagnostic accuracy in TES, with a possible impact on therapeutic results. Chest CT is essential for detecting bullous lesions, aiding in intraoperative identification and surgical treatment. Immunohistochemistry (IHC), assessing estrogen receptor (ER) and CD10 for stromal identification, improves pathological accuracy. This study underlines the diagnostic value of integrating imaging, intraoperative assessment, and targeted histopathology, as well as clear communication between surgeons, radiologists, and pathologists to ensure accurate diagnosis and an improved therapeutic process for patients in clinical practice.
- 15 October 2026
- Published by Wroclaw Medical University in Advances in Clinical and Experimental Medicine
- Vol. 35 (10) , 1747-1756
Open AccessA multidisciplinary diagnostic approach to thoracic endometriosis syndrome: Insights from CT imaging, surgery, and pathology
Thoracic endometriosis syndrome (TES) is the most common extrapelvic manifestation of endometriosis, yet its classification, diagnosis, and treatment remain debated. Thoracic endometriosis syndrome has recently been proposed to be categorized into 3 types: pleural, bronchopulmonary, and diaphragmatic. Our study aims to propose a 3-step approach - computed tomography (CT) imaging, careful intraoperative assessment, and targeted pathology - to enhance the diagnostic process and optimize the management of TES-related pneumothorax. We retrospectively analyzed 3 cases of recurrent right-sided catamenial pneumothorax in female patients with a history of pelvic endometriosis, managed surgically at the Department of Thoracic Surgery, Medical University of Gdansk, between 2021 and 2024. All included patients underwent video-assisted thoracoscopic surgery (VATS), with comprehensive preoperative CT imaging, intraoperative lesion mapping, and postoperative histopathological examination, improving diagnostic accuracy in TES, with a possible impact on therapeutic results. Chest CT is essential for detecting bullous lesions, aiding in intraoperative identification and surgical treatment. Immunohistochemistry (IHC), assessing estrogen receptor (ER) and CD10 for stromal identification, improves pathological accuracy. This study underlines the diagnostic value of integrating imaging, intraoperative assessment, and targeted histopathology, as well as clear communication between surgeons, radiologists, and pathologists to ensure accurate diagnosis and an improved therapeutic process for patients in clinical practice.
- Open Access
- 1 June 2026
- Published by AME Publishing Company in Translational Lung Cancer Research
- Vol. 15 (6) , 182
Inconsistent definitions of radical resection in perioperative trials of non-small cell lung cancer: a scoping review
Background: Perioperative therapies have altered curative-intent treatment for resectable non-small cell lung cancer (NSCLC). Nonetheless, radical resection (R0) still remains one of the most vital determinants of the final clinical outcome. This study evaluates the definition of radical resection across perioperative NSCLC trials in the context of the National Comprehensive Cancer Network (NCCN) and International Association for the Study of Lung Cancer (IASLC) guidelines. Methods: A scoping review in accordance with PRISMA-ScR 2018 guidelines was conducted to identify suitable clinical trial protocols. PubMed and ClinicalTrials.gov were searched for trials published between 2020 and 2025, focusing on studies with full protocols in English that included surgical treatment of NSCLC. Surgical radicality and lymphadenectomy definitions provided in the protocols were extracted and evaluated for adherence to NCCN and IASLC guidelines. Each component was assigned a value of ‘1’ if the criterion was met and ‘0’ if it was not. These binary scores were subsequently used to assess the overall compliance with the guidelines. Results: Out of 563 records initially identified, 47 were ultimately included. Only 15% of studies fully met the radical resection criteria according to both the NCCN and IASLC guidelines. As for lymphadenectomy, 30% of studies adhered to the NCCN guidelines, while 15% followed the IASLC guidelines. Conclusions: These findings highlight the persistent lack of a clear and uniform definition of radical resection in NSCLC amongst trial protocols. Such heterogeneity pose difficulty in interpretability and comparability of clinical data. It is of utmost importance to reinforce a trend toward standardization, for the sake of both patients and physicians.
- 1 June 2026
- Published by AME Publishing Company in Translational Lung Cancer Research
- Vol. 15 (6) , 182
Open AccessInconsistent definitions of radical resection in perioperative trials of non-small cell lung cancer: a scoping review
Background: Perioperative therapies have altered curative-intent treatment for resectable non-small cell lung cancer (NSCLC). Nonetheless, radical resection (R0) still remains one of the most vital determinants of the final clinical outcome. This study evaluates the definition of radical resection across perioperative NSCLC trials in the context of the National Comprehensive Cancer Network (NCCN) and International Association for the Study of Lung Cancer (IASLC) guidelines. Methods: A scoping review in accordance with PRISMA-ScR 2018 guidelines was conducted to identify suitable clinical trial protocols. PubMed and ClinicalTrials.gov were searched for trials published between 2020 and 2025, focusing on studies with full protocols in English that included surgical treatment of NSCLC. Surgical radicality and lymphadenectomy definitions provided in the protocols were extracted and evaluated for adherence to NCCN and IASLC guidelines. Each component was assigned a value of ‘1’ if the criterion was met and ‘0’ if it was not. These binary scores were subsequently used to assess the overall compliance with the guidelines. Results: Out of 563 records initially identified, 47 were ultimately included. Only 15% of studies fully met the radical resection criteria according to both the NCCN and IASLC guidelines. As for lymphadenectomy, 30% of studies adhered to the NCCN guidelines, while 15% followed the IASLC guidelines. Conclusions: These findings highlight the persistent lack of a clear and uniform definition of radical resection in NSCLC amongst trial protocols. Such heterogeneity pose difficulty in interpretability and comparability of clinical data. It is of utmost importance to reinforce a trend toward standardization, for the sake of both patients and physicians.